Rosen, a leading law firm, encourages acutus medical, inc. investors with losses to secure counsel before important deadline in securities class action – afib

New york--(business wire)-- #afib--why: rosen law firm, a global investor rights law firm, reminds purchasers of the securities of acutus medical, inc. (nasdaq: afib) between may 13, 2021 and november 11, 2021, inclusive (the “class period”) of the important april 18, 2022 lead plaintiff deadline. so what: if you purchased acutus medical securities during the class period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. what t
AFIB Ratings Summary
AFIB Quant Ranking